Introduction
============

Dermatomyositis (DM) is a rare disorder of variable severity, ranging from mild weakness that is highly responsive to corticosteroid therapy to a relentless downhill course with pulmonary involvement that is unresponsive to all immunosuppressive modalities.

Method
======

In this retrospective case series, we reviewed the clinical presentation and outcomes of all DM patients who were admitted to the medical intensive care unit (MICU) of a university-affiliated general hospital from 1 January 2000 to 31 December 2004. All had acute respiratory failure requiring mechanical ventilation (MV).

Results
=======

The nine patients had a mean age of 47.6 ± 12.4 (range: 27--66) years. The female to male ratio was 3.5:1. All were diagnosed to have DM before MICU admission with median duration of illness of 8 (range: 3--28) weeks. DM was classified as classical (Peter and Bohan\'s criteria) in six patients and amyopathic (Sontheimer\'s criteria) in three. Initial high-resolution computed tomography thorax in eight patients showed pulmonary fibrosis (four patients), interstitial/alveolar changes (two patients), and ground-glass changes (two patients). All patients were negative for anti-Jo1 antibody, and none had an associated malignancy.

The mean PaO~2~/FiO~2~was 109.2 ± 40.9 (range: 61.8--181.7) mmHg. The median duration of hospital and MICU stay were 16 (range: 2--38) days and 13 (range: \<1 to 37) days, respectively. The median duration of MV was 10 (range: \<1 to 37) days.

All chest radiographs showed bilateral lung infiltrates. Broncho-alveolar lavage was performed on six patients, with findings of pneumocystis cariini in one patient and mycobacterium tuberculosis in another. All patients were treated empirically with broad-spectrum antibiotics for pneumonia including cotrimoxazole for *Pneumocystis carinii*on admission to the MICU. Immunosuppressive therapies in the MICU included high-dose systemic corticosteroids in all, pulse methylprednisolone (five patients), pulse cyclophosphamide (three patients), high-dose intravenous immunoglobulin (one patient) and cyclosporine (two patients). All patients died of respiratory failure with four having hypotension and acute renal failure as contributing causes.

Conclusion
==========

DM with pulmonary involvement that required MV carries an extremely high mortality. Early diagnosis and effective immunosuppressive therapies for lung disease may help to improve outcome in this high-risk group.
